Guangshengtang (300436.SZ): The company's innovative drug GST-HG131 for Hepatitis B treatment is planned to be included in the breakthrough therapy list, which is still in the public notice period.

Zhito Finance APP News, Guangsheng Tang (300436.SZ) announced that the company's stock has deviated by more than 30% from the closing price for three consecutive trading days from July 2 to July 4, 2025. According to the "Shenzhen Stock Exchange Trading Rules," this situation is considered abnormal stock trading volatility.